Login to Your Account

Hyseq, Variagenics To Merge In $55.9M Stock Transaction

By Brady Huggett

Tuesday, November 12, 2002
It has been a year of downsizing and restructuring, and the long list of companies that have done so include Hyseq Pharmaceuticals Inc. and Variagenics Inc. Those two slimmed-down companies - one focused on drug discovery and one on diagnostics - said Monday they were merging in a stock deal valued at about $56 million. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription